Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

Katherine Cameron; Sivan Golan; William Simpson; Steven Peti; Sasan Roayaie; Daniel Labow; Lale Kostakoglu

doi:10.1007/s00261-011-9729-6

Recurrent pancreatic carcinoma and cholangiocarcinoma: ¹⁸F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

Katherine Cameron, Sivan Golan, William Simpson, Steven Peti, Sasan Roayaie, Daniel Labow, Lale Kostakoglu

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Abstract

Although the current literature is limited, available data suggest that ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

Original language	English
Pages (from-to)	463-471
Number of pages	9
Journal	Abdominal Imaging
Volume	36
Issue number	4
DOIs	https://doi.org/10.1007/s00261-011-9729-6
State	Published - Aug 2011

Keywords

Cholangiocarcinoma
Oncology
PET/CT
Pancreatic carcinoma
Recurrence
Restaging

Access to Document

10.1007/s00261-011-9729-6

Cite this

@article{6ca113fa41e0447a9f109b048b358b03,

title = "Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)",

abstract = "Although the current literature is limited, available data suggest that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.",

keywords = "Cholangiocarcinoma, Oncology, PET/CT, Pancreatic carcinoma, Recurrence, Restaging",

author = "Katherine Cameron and Sivan Golan and William Simpson and Steven Peti and Sasan Roayaie and Daniel Labow and Lale Kostakoglu",

year = "2011",

month = aug,

doi = "10.1007/s00261-011-9729-6",

language = "English",

volume = "36",

pages = "463--471",

journal = "Abdominal Imaging",

issn = "0942-8925",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Recurrent pancreatic carcinoma and cholangiocarcinoma

T2 - 18F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

AU - Cameron, Katherine

AU - Golan, Sivan

AU - Simpson, William

AU - Peti, Steven

AU - Roayaie, Sasan

AU - Labow, Daniel

AU - Kostakoglu, Lale

PY - 2011/8

Y1 - 2011/8

N2 - Although the current literature is limited, available data suggest that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

AB - Although the current literature is limited, available data suggest that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

KW - Cholangiocarcinoma

KW - Oncology

KW - PET/CT

KW - Pancreatic carcinoma

KW - Recurrence

KW - Restaging

UR - https://www.scopus.com/pages/publications/80052405115

U2 - 10.1007/s00261-011-9729-6

DO - 10.1007/s00261-011-9729-6

M3 - Article

C2 - 21465110

AN - SCOPUS:80052405115

SN - 0942-8925

VL - 36

SP - 463

EP - 471

JO - Abdominal Imaging

JF - Abdominal Imaging

IS - 4